Search Results

There are 11701 results for: content related to: Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis

  1. You have free access to this content
    Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 421–429, Norio Akuta, Fumitaka Suzuki, Miharu Hirakawa, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Kazuaki Chayama, Yusuke Nakamura and Hiromitsu Kumada

    Version of Record online : 26 MAR 2010, DOI: 10.1002/hep.23690

  2. Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non-responders infected with HCV genotype 1

    Journal of Medical Virology

    Volume 84, Issue 7, July 2012, Pages: 1097–1105, Norio Akuta, Fumitaka Suzuki, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 14 MAY 2012, DOI: 10.1002/jmv.23262

  3. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Version of Record online : 30 SEP 2013, DOI: 10.1002/phar.1349

  4. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  5. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  6. You have free access to this content
    Role of IL28B for chronic hepatitis C treatment toward personalized medicine

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 241–249, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Version of Record online : 27 JAN 2014, DOI: 10.1111/jgh.12475

  7. You have free access to this content
    Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response

    Hepatology

    Volume 55, Issue 1, January 2012, Pages: 20–29, Yasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, Keisuke Tanaka, Yuichiro Suzuki, Nobuharu Tamaki, Yoshihide Hoshioka, Yutaka Yasui, Tomoji Katoh, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Sayuri Nitta, Naoya Sakamoto and Namiki Izumi

    Version of Record online : 29 NOV 2011, DOI: 10.1002/hep.24623

  8. Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b

    Journal of Medical Virology

    Volume 85, Issue 7, July 2013, Pages: 1180–1190, Kai Yoshizawa, Hiroshi Abe, Yuta Aida, Haruya Ishiguro, Makiko Ika, Noritomo Shimada, Akihito Tsubota and Yoshio Aizawa

    Version of Record online : 22 MAY 2013, DOI: 10.1002/jmv.23597

  9. Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1

    Journal of Medical Virology

    Volume 85, Issue 6, June 2013, Pages: 1028–1036, Norio Akuta, Fumitaka Suzuki, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Tasuku Hara, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 12 APR 2013, DOI: 10.1002/jmv.23579

  10. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy

    Journal of Medical Virology

    Volume 83, Issue 6, June 2011, Pages: 1016–1022, Norio Akuta, Fumitaka Suzuki, Miharu Hirakawa, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 18 APR 2011, DOI: 10.1002/jmv.22094

  11. You have free access to this content
    IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C

    Hepatology

    Volume 52, Issue 6, December 2010, Pages: 1888–1896, Thomas J. Urban, Alexander J. Thompson, Shelton S. Bradrick, Jacques Fellay, Detlef Schuppan, Kenneth D. Cronin, Linda Hong, Alexander McKenzie, Keyur Patel, Kevin V. Shianna, John G. McHutchison, David B. Goldstein and Nezam Afdhal

    Version of Record online : 7 OCT 2010, DOI: 10.1002/hep.23912

  12. Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma

    Journal of Medical Virology

    Volume 84, Issue 8, August 2012, Pages: 1199–1207, Makiko Takeyasu, Norio Akuta, Fumitaka Suzuki, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 18 JUN 2012, DOI: 10.1002/jmv.23288

  13. Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 6, June 2015, Pages: 1075–1084, Miyako Murakawa, Yasuhiro Asahina, Mina Nakagawa, Naoya Sakamoto, Sayuri Nitta, Akiko Kusano-Kitazume, Takako Watanabe, Fukiko Kawai-Kitahata, Satoshi Otani, Miki Taniguchi, Fumio Goto, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma and Mamoru Watanabe

    Version of Record online : 27 APR 2015, DOI: 10.1111/jgh.12902

  14. You have free access to this content
    Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 2, July 2012, Pages: 91–103, Y. Chen, H.-X. Xu, L.-J. Wang, X.-X. Liu, R. I. Mahato and Y.-R. Zhao

    Version of Record online : 16 MAY 2012, DOI: 10.1111/j.1365-2036.2012.05131.x

  15. Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1208–1216, Kentaro Matsuura, Tsunamasa Watanabe, Sayuki Iijima, Shuko Murakami, Kei Fujiwara, Etsuro Orito, Etsuko Iio, Mio Endo, Atsunori Kusakabe, Noboru Shinkai, Tomokatsu Miyaki, Shunsuke Nojiri, Takashi Joh and Yasuhito Tanaka

    Version of Record online : 17 FEB 2014, DOI: 10.1111/hepr.12294

  16. Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy

    Journal of Medical Virology

    Volume 84, Issue 10, October 2012, Pages: 1593–1599, Norio Akuta, Fumitaka Suzuki, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 15 AUG 2012, DOI: 10.1002/jmv.23368

  17. The importance of IL28B genotype in hepatitis C virus-associated liver transplantation

    Liver International

    Volume 33, Issue 2, February 2013, Pages: 169–171, Christian M. Lange

    Version of Record online : 7 JAN 2013, DOI: 10.1111/liv.12071

  18. You have free access to this content
    Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1548–1557, Mazen Noureddin, Elizabeth C. Wright, Harvey J. Alter, Shauna Clark, Emmanuel Thomas, Richard Chen, Xiongce Zhao, Cathy Conry-Cantilena, David E. Kleiner, T. Jake Liang and Marc G. Ghany

    Version of Record online : 30 SEP 2013, DOI: 10.1002/hep.26506

  19. You have free access to this content
    IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 74–78, Donald M. Jensen and Stanislas Pol

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02712.x

  20. You have free access to this content
    Hepatitis C pharmacogenetics: State of the art in 2010

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 336–345, Nezam H. Afdhal, John G. McHutchison, Stefan Zeuzem, Alessandra Mangia, Jean-Michel Pawlotsky, Jeffrey S. Murray, Kevin V. Shianna, Yasuhito Tanaka, David L. Thomas, David R. Booth, David B. Goldstein and for the Pharmacogenetics and Hepatitis C Meeting Participants

    Version of Record online : 12 JAN 2011, DOI: 10.1002/hep.24052